drugset
drugset / Trial / NCT06185361

Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.

NCT06185361 ↗

Unknown 60 enrolled Fayoum University Hospital
RandomizedSingle-groupSingle-blindTreatment

Summary

To determine whether there is a role for the selective serotonin reuptake inhibitors fluoxetine versus desmopressin in the treatment of nocturnal enuresis in children who have not responded to standard nonpharmacological urotherapy, and whether there are side effects involved.

Timeline

Start
2022-12-01
Primary completion
2024-03-01
Completion
2024-03-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Desmopressin Peptide 0.2 mg Oral
Comparator Fluoxetine Small molecule 20 mg —

Indications

enuresis, nocturnal, 1